HomeDMYD-B • STO
add
Diamyd Medical AB
Nakaraang pagsara
kr 13.20
Sakop ng araw
kr 12.90 - kr 13.36
Sakop ng taon
kr 6.41 - kr 25.00
Market cap
1.35B SEK
Average na Volume
162.91K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Ago 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 18.00K | -75.68% |
Gastos sa pagpapatakbo | 51.15M | 40.41% |
Net na kita | -49.74M | -32.59% |
Net profit margin | -276.33K | -445.11% |
Kita sa bawat share | — | — |
EBITDA | -45.08M | -25.02% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Ago 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 132.37M | 3.79% |
Kabuuang asset | 217.04M | 5.46% |
Kabuuang sagutin | 71.12M | 95.32% |
Kabuuang equity | 145.92M | — |
Natitirang share | 99.72M | — |
Presyo para makapag-book | 9.04 | — |
Return on assets | -55.84% | — |
Return on capital | -76.10% | — |
Cash Flow
Net change in cash
| (SEK) | Ago 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -49.74M | -32.59% |
Cash mula sa mga operasyon | -29.16M | 15.54% |
Cash mula sa pag-invest | 18.79M | 886.03% |
Cash mula sa financing | -838.00K | -100.97% |
Net change in cash | -10.27M | -120.46% |
Malayang cash flow | -12.59M | 50.11% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
25
